Lv2
130 积分 2023-04-06 加入
2023 updated MASCC/ESMO Consensus recommendations: Prevention of nausea and vomiting following moderately emetic risk antineoplastic agents
16小时前
已完结
Fourth Consensus Guidelines for the Management of Postoperative Nausea and Vomiting
17小时前
已完结
La classification de l’OMS 2021 des tumeurs du système nerveux central
11天前
已完结
APF530 (Granisetron Injection Extended-Release) in a Three-Drug Regimen for Delayed CINV in Highly Emetogenic Chemotherapy
1个月前
已完结
APF530 (Granisetron Injection Extended-Release) in a Three-Drug Regimen for Delayed CINV in Highly Emetogenic Chemotherapy
1个月前
已关闭
APF530 (Granisetron Injection Extended-Release) in a Three-Drug Regimen for Delayed CINV in Highly Emetogenic Chemotherapy
1个月前
已关闭
APF530 (Granisetron Injection Extended-Release) in a Three-Drug Regimen for Delayed CINV in Highly Emetogenic Chemotherapy
1个月前
已关闭
[A new antiemetic ramosetron hydrochloride]
1个月前
已关闭
A Randomised Crossover Study Comparing Ramosetron plus Dexamethasone with Ramosetron Alone in the Prevention of Cisplatin-Induced Emesis
1个月前
已完结
Ramosetron for the Prevention of Cisplatin-Induced Acute Emesis: A Prospective Randomized Comparison with Granisetron
1个月前
已完结
皖公网安备34019202002308
